Xact Kapitalforvaltning’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$219K Hold
8,116
﹤0.01% 1171
2019
Q4
$274K Hold
8,116
﹤0.01% 1275
2019
Q3
$304K Hold
8,116
0.01% 1193
2019
Q2
$354K Hold
8,116
0.01% 1125
2019
Q1
$346K Hold
8,116
0.01% 1135
2018
Q4
$364K Hold
8,116
0.01% 1110
2018
Q3
$556K Buy
8,116
+600
+8% +$38.6K 0.01% 887
2018
Q2
$430K Buy
7,516
+800
+12% +$42.3K 0.01% 1058
2018
Q1
$309K Buy
6,716
+1,300
+24% +$61.7K 0.01% 1224
2017
Q4
$250K Buy
+5,416
New +$249K 0.01% 1076

Other funds holding AVNS

Xact Kapitalforvaltning's AVNS Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Avanos Medical (AVNS) position steady in Q1 2020 at 8,116 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1171.

Xact Kapitalforvaltning first reported a position in AVNS in Q4 2017 and has held it in 10 quarters since. The position peaked at $556K in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Xact Kapitalforvaltning held 8,116 shares of Avanos Medical worth $219K as of Q1 2020.
  • Xact Kapitalforvaltning left its Avanos Medical share count unchanged in Q1 2020.
  • Avanos Medical made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1171 holding.
  • Xact Kapitalforvaltning first reported a position in Avanos Medical in Q4 2017 and has held it in 10 quarters since.
  • Xact Kapitalforvaltning's Avanos Medical position peaked at $556K in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.